Eris Lifesciences Limited (BOM:540596)
1,281.10
+29.70 (2.37%)
At close: Feb 19, 2025
Eris Lifesciences Statistics
Total Valuation
BOM:540596 has a market cap or net worth of INR 174.13 billion. The enterprise value is 203.11 billion.
Market Cap | 174.13B |
Enterprise Value | 203.11B |
Important Dates
The next estimated earnings date is Friday, May 23, 2025.
Earnings Date | May 23, 2025 |
Ex-Dividend Date | Feb 13, 2025 |
Share Statistics
Current Share Class | n/a |
Shares Outstanding | n/a |
Shares Change (YoY) | -0.03% |
Shares Change (QoQ) | -0.07% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 40.74M |
Valuation Ratios
The trailing PE ratio is 52.87.
PE Ratio | 52.87 |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | n/a |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | 61.67 |
EV / Sales | 7.46 |
EV / EBITDA | 23.85 |
EV / EBIT | 32.56 |
EV / FCF | n/a |
Financial Position
Current Ratio | n/a |
Quick Ratio | n/a |
Debt / Equity | 0.86 |
Debt / EBITDA | 3.21 |
Debt / FCF | n/a |
Interest Coverage | 2.97 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Invested Capital (ROIC) | 8.50% |
Return on Capital Employed (ROCE) | n/a |
Revenue Per Employee | 7.52M |
Profits Per Employee | 909,815 |
Employee Count | 3,620 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +50.25% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | +50.25% |
50-Day Moving Average | 1,300.42 |
200-Day Moving Average | 1,230.68 |
Relative Strength Index (RSI) | 48.47 |
Average Volume (20 Days) | 8,273 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:540596 had revenue of INR 27.24 billion and earned 3.29 billion in profits. Earnings per share was 24.18.
Revenue | 27.24B |
Gross Profit | 20.46B |
Operating Income | 6.24B |
Pretax Income | 4.37B |
Net Income | 3.29B |
EBITDA | 8.40B |
EBIT | 6.24B |
Earnings Per Share (EPS) | 24.18 |
Balance Sheet
The company has 2.43 billion in cash and 27.35 billion in debt, giving a net cash position of -24.92 billion.
Cash & Cash Equivalents | 2.43B |
Total Debt | 27.35B |
Net Cash | -24.92B |
Net Cash Per Share | n/a |
Equity (Book Value) | 31.77B |
Book Value Per Share | 203.65 |
Working Capital | n/a |
Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross margin is 75.10%, with operating and profit margins of 22.90% and 12.09%.
Gross Margin | 75.10% |
Operating Margin | 22.90% |
Pretax Margin | 16.05% |
Profit Margin | 12.09% |
EBITDA Margin | 30.84% |
EBIT Margin | 22.90% |
FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 7.35, which amounts to a dividend yield of 0.57%.
Dividend Per Share | 7.35 |
Dividend Yield | 0.57% |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | 1 |
Payout Ratio | n/a |
Buyback Yield | 0.03% |
Shareholder Yield | 0.61% |
Earnings Yield | 1.89% |
FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |